Physician profile
Kimberly Thorguson
NPI 1396731261
$1,728.04
in general payments reported to CMS, 2019-2025
18 companies · $378 in 2025
The $378 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $162 · 2021: $161 · 2022: $208 · 2023: $314 · 2024: $326 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $390.19 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $221.61 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $200.54 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Pfizer INC. | $172.93 | 2019-2025 | |
| Sanofi Pasteur INC. | $155.22 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $119.57 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $110.82 | 2019-2025 | Bexsero, Rotarix, Penmenvy |
| Takeda Pharmaceuticals U.S.A., INC. | $109.44 | 2020-2022 | |
| Shire North American Group INC | $47.28 | 2019 | |
| Supernus Pharmaceuticals, INC. | $36.31 | 2021-2025 | Qelbree |
| Cranial Technologies, INC | $35.50 | 2025 | Doc Band |
| Seqirus USA INC | $20.89 | 2024 | Flucelvax |
| Sobi, INC | $20.08 | 2021 | |
| Tris Pharma INC | $19.25 | 2025 | Dyanavel Xr |
| Verrica Pharmaceuticals INC. | $18.28 | 2025 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.42 | 2023 | Flumist Quadrivalent |
| Genzyme Corporation | $16.44 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Thorguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.